Company News - Canton Biologics

中文

Search

Home

About us

About us

Management Team

Corporate Culture

Services & Solutions

R&D

Antibody Discovery Developability Assessment

Development

Cell Line

Cell Line Development High-Efficiency Expression Vector

Process Analytical Methods Microbial CGT

Manufacturing

Tech Transfer Drug Substance Drug Product Process Characterization Process Validation

Quality & Support

Quality Control Quality Assurance Regulatory Affairs Project Management IP Management

Animal Health

Case Studies & Experience

Technology Platforms

Cell Line Platform

CHOzen® CHOFlow® GS-KO GlycoExpress® Other Commercial Cell Lines Canvector®

Process Development Platform

CHO-Rise® CBoost® CanPure™ Purification Platform CanCapture™ Membrane Chromatography Platform CanConcentra™ High-Concentration Formulation Platform

Manufacturing Platform

Scale-Plus Technology Biologics Pulsing Production Line

IgMaxTM

News

Company News

Brochures & Materials

Join Us

Contact Us

Contact Information

Leave a Message

类别产品类型领域

2026-03-24 17:37:20

National "Little Giant" Enterprise Officially Awarded, Canton Biologics is the Only Listed Biologics CDMO!

On December 21, 2023, the award ceremony for the fifth batch of National "Little Giant" Enterprises, organized by the Ministry of Industry and Information Technology, concluded successfully.

Explore More

Company News

Brochures & Materials

【Badminton with You, Cultivating the Future Together】The 6th Bio-Engine "Co-Cultivation Cup" Badminton Tournament 2025 Concludes with Passion!

Though winter brings cold weather, the competition arena was filled with blazing passion! To promote interaction among colleagues from different office locations and enrich employees' after-work life, the 6th Bio-Engine "Co-Cultivation Cup" Badminton Tournament, jointly organized by the Administration Department, Bio-Engine Badminton Association, and Gaoteng Labor Union, and generously sponsored by Bio-Engine (Shanghai) Bio-Pharmaceutical Co., Ltd., concluded successfully on December 26, 2025.

【Event Recap】Tackling "Hard-to-Express" Antibodies: Bio-Engine Showcases Solutions for Industrialization Challenges

On December 19, the "Antibody Process 'Intelligence' Summit – From Lean to Excellence in Industrialization Practice" themed salon, hosted by Tofflon Life Sciences, was successfully held in Guangzhou. Dr. Qianhui Liang, Director of Cell Line and Upstream Process Development at Bio-Engine, was invited to attend and delivered a keynote speech titled "Technical Challenges and Response Strategies for High-Challenge Monoclonal Antibody Development: From Hard-to-Express Antibodies to Quality Regulation and Abnormal Characterization Analysis."

Event Recap: Canton Biologics Appears at Sun Yat-sen University Biopharmaceutical Industry Alliance Forum

2024年11月11日，汉腾生物在广州参加了由中山大学主办的“中山大学生物医药产业联盟论坛”。本次论坛汇聚了生物医药领域的顶尖专家和中山大学的优秀硕博士人...

National "Little Giant" Enterprise Officially Awarded, Canton Biologics is the Only Listed Biologics CDMO!

On December 21, 2023, the award ceremony for the fifth batch of National "Little Giant" Enterprises, organized by the Ministry of Industry and Information Technology, concluded successfully.

Good News | Canton Biologics Selected for 2025 Guangzhou “Future Unicorn” Innovative Enterprise List

Recently, under the guidance of the Guangzhou Municipal Science and Technology Bureau, the “2025 Discovering Guangzhou Unicorn Innovative Enterprises” list, organized by the Guangzhou Science and Technology Innovation Enterprise Association and co-initiated by institutions including the Guangzhou Industrial Development Research Institute, was officially announced. Following a rigorous selection process, Guangzhou Canton Biologics Technology Co., Ltd. was successfully selected for the 2025 Guangzhou “Future Unicorn” Innovative Enterprise List, owing to its outstanding technological innovation capabilities and high growth potential in the biopharmaceutical CDMO sector.

Subscribe for Updates

About us

About us Management Team Corporate Culture

Services & Solutions

R&D Development Manufacturing Quality & Support Animal Health Case Studies & Experience

Technology Platforms

Cell Line Platform Process Development Platform Manufacturing Platform IgMaxTM

Contact Us

Contact Information Leave a Message

Copyright © 2025 Guangzhou HanTen Biotech Co., Ltd. All Rights Reserved.

Privacy Policy|Yue ICP No. 16115190|Powered by szweb